Search for: "RISING PHARMACEUTICALS, INC."
Results 1 - 20
of 465
Sort by Relevance
|
Sort by Date
9 Apr 2024, 2:56 pm
Proc. 97-35, and cases like RJR Nabisco, Inc. v. [read post]
25 Jan 2024, 6:06 pm
With many American businesses still operating with some of their work-force at home post-pandemic, and rising interest rates, commercial real estate is taking a hit. [read post]
21 Jan 2024, 9:01 pm
In Seven & i Holdings Co., Ltd. and 7-Eleven, Inc. [read post]
2 Jan 2024, 12:56 pm
Thus, by my tally there were 25 securities class action lawsuits filed against companies in the 283 SIC Code Industry Group (Drugs), including 17 in the 2834 SIC Code category (Pharmaceutical Preparations). [read post]
21 Dec 2023, 9:34 am
Collegium Pharmaceutical, Inc. 2022-1482 (Fed. [read post]
5 Dec 2023, 1:30 am
”In connection with the lawsuit, the congregations of Catholic Sisters released the following joint statement:As Catholic Sisters and women of faith who believe in the sanctity of life, our hearts ache at the exponential rise in gun deaths and mass shootings in our country that have ravaged the lives of so many children, women, men, their families, and communities. [read post]
28 Nov 2023, 5:24 am
Levine, 555 U.S. 555 (2009) Mutual Pharmaceutical Co., Inc. v. [read post]
12 Jun 2023, 1:09 pm
In Matrixx Initiatives, Inc. v. [read post]
9 Jun 2023, 8:36 am
In Part One, I reviewed the basic structure and function of the pharmaceutical industry, as well as the theory of harm that the FTC is bringing. [read post]
9 Jun 2023, 8:36 am
In Part One, I reviewed the basic structure and function of the pharmaceutical industry, as well as the theory of harm that the FTC is bringing. [read post]
1 May 2023, 10:11 am
Teva Pharmaceuticals USA, Inc. v. [read post]
27 Mar 2023, 9:01 pm
Figure 5: Finally, as shown in Figure 6, Median NERA-Defined Investor Losses increased in 2022, rising to$972 million from $731 million in 2021. [read post]
1 Feb 2023, 9:05 pm
Pfizer was a major contributor to the level of healthcare M&A, announcing a number of deals, including its $11.6 acquisition of Biohaven Pharmaceuticals, $5.4 billion acquisition of Global Blood Therapeutics and $525 million acquisition of ReViral. [read post]
31 Jan 2023, 6:36 pm
Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986). [read post]
3 Jan 2023, 1:47 pm
The directors’ and officers’ liability environment is always changing, but 2022 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
8 Dec 2022, 5:34 am
Executive Health Resources, Inc. [read post]
5 Dec 2022, 1:03 pm
After Accredo told the two charities that it planned to reduce the amount of donations in the following year, one of the two charities, Hemophilia Services, Inc. [read post]
28 Nov 2022, 10:27 am
Vital Pharmaceuticals, Inc., 2022 WL 17218077, No. [read post]
11 Nov 2022, 9:40 am
Cir. 2021); Plexxikon Inc. v. [read post]
22 Sep 2022, 9:54 am
AbbVie Inc, 7th U.S. [read post]
